Serotonergic gene transcriptional control regions: Targets for antidepressant drug development?

International Journal of Neuropsychopharmacology

Volumn 3, Issue 1, 2000, Pages 67-79

  Lesch, Klaus Peter ^a   Heils, Armin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antidepressants; Anxiety; Depression; Gene regulation; Gene transfer; Serotonin; Vital vectors

Indexed keywords

ADENYLATE CYCLASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANTIDEPRESSANT AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; VIRUS VECTOR;

AGGRESSION; ANXIETY; ARTICLE; DEPRESSION; DRUG RESEARCH; GENE TARGETING; HUMAN; NERVE CELL PLASTICITY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034130404     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145700001747     Document Type: Article

References (78)

1. Abbar M, Courtet P, Amadeo S, Caer Y, Mallet J, Baldy-Moulinier M, Castelnau D, Malafosse A (1995). Suicidal behaviors and the tryptophan hydroxylase gene. Archives of General Psychiatry 52, 846-849.
2. Albert PR, Lembo P, Storring JM, Charest A, Saucier C (1996). The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 14, 19-25.
3. Amado RG, Chen ISY (1999). Lentiviral vectors - the promise of gene therapy within reach? Science 285, 674-676.
4. Azmitia EC, Whitaker-Azmitia PM (1997). Development and adult plasticity of serotonergic neurons and their target cells. In: Baumgarten HG, Göthert M (Eds.), Serotonergic Neurons and 5-HT Receptors in the CNS (pp. 1-39). New York: Springer, Berlin, Heidelberg.
5. Bedford FK, Julius D, Ingraham HA (1998). Neuronal expression of the 5HT3 serotonin receptor gene requires nuclear factor 1 complexes. Journal of Neuroscience 18, 186-194.
6. Bengel D, Heils A, Petri S, Teufel A, Seemann M, Riederer P, Murphy DL, Lesch KP (1996). Gene structure and 5′-flanking regulatory region of the murine serotonin transporter. Molecular Brain Research 778, 338-345.
7. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP (1998). Altered brain serotonin (5-HT) homeostasis and locomoter insensitivity to MDMA ('ecstasy') in 5-HT transporter-deficient mice. Molecular Pharmacology 53, 649-655.
8. Bhat RV, Cole AJ, Baraban JM (1992). Role of monoamine systems in activation of zif268 by cocaine. Journal of Psychiatry and Neuroscience 17, 94-102.
9. Blakely R, De Felice LJ, Hartzell HC (1994). Molecular physiology of norepinephrine and serotonin transporters. Journal of Experimental Biology 196, 263-281.
10. Bloem LJ, Chen Y, Liu J, Bye LS, Yu L (1993). Analysis of the promoter sequence and the transcription initiation site of the mouse 5-HT1C serotonin receptor gene. Molecular Brain Research 17, 194-200.
11. Blömer U, Naldini L, Verma IM, Trono D, Gage FH (1996). Applications of gene therapy to the CNS. Human Molecular Genetics 5, 1397-1404.
12. Boularand S, Darmon MC, Mallet J (1995). The human tryptophan hydroxylase gene. An unusual splicing complexity in the 5′-untranslated region. Journal of Biological Chemistry 270, 3748-3756.
13. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580.
14. Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E (1996). Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Molecular Pharmacology 50, 799-807.
15. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: Role of a serotonin excess during the critical period. Neuron 16, 297-307.
16. Chalmers DT, Lopez JF, Vazquez DM, Akil H, Watson SJ (1994). Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology 10, 215-222.
17. Chaouloff F (1995). Regulation of 5-HT receptors by corticosteroids: where do we stand? Fundamental Clinical Pharmacology 9, 219-233.
18. Corti O, Horellou P, Colin P, Cattaneo E, Mallet U (1996). Intracerebral tetracycline-dependent regulation of gene expression in grafts of neural precursors. NeuroReport 7, 1655-1659.
19. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999). The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397, 359-363.
20. Davies SJA, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J (1997). Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390, 680-683.
21. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics 8, 621-624.
22. Denney RM, Sharma A, Dave SK, Waguespack A (1994). A new look at the promoter of the human monoamine oxidase A gene: mapping transcription initiation sites and capacity to drive luciferase expression. Journal of Neurochemistry 63, 843-856.
23. Ding D, Toth M, Zhou Y, Parks C, Hoffman BJ, Shenk T (1993). Glia cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter. Molecular Brain Research 20, 181-191.
24. Du YL, Wilcox BD, Jeffrey JJ (1995). Regulation of rat 5-hydroxytryptamine type 2 receptor gene activity: identification of cis elements that mediate basal and 5-hydroxytryptamine-dependent gene activation. Molecular Pharmacology 47, 915-922.
25. Du YL, Wilcox BD, Teitler M, Jeffrey JJ (1994). Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Molecular Pharmacology 45, 1125-1131.
26. Duman RS (1998). Novel therapeutic approaches beyond the serotonin receptor. Biological Psychiatry 44, 324-335.
27. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC (1998). Analysis and metaanalysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics 81, 58-63.
28. Garlow SJ, Chin AC, Marinovich AM, Heller MR, Ciaranello RD (1994). Cloning and functional mapping of the rat serotonin-2 receptor gene. Molecular and Cellular Neuroscience 5, 291-300.
29. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJ, Hartig PR, Branchek TA (1995). The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO Journal 14, 2806-2815.
30. Gold SJ, Ni YG, Dohlman HG, Nestler EJ (1997). Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. Journal of Neuroscience 17, 8024-8037.
31. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics 88, 83-87.
32. Hanna GL, Himle JA, Curtis GC, Koram DQ, Veenstra-Vander Weele J, Leventhal BL, Cook EH (1998). Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 18, 102-111.
33. Heidmann DE, Metcalf MA, Kohen R, Hamblin MW (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. Journal of Neuochemitry 68, 1372-8131.
34. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U, Riederer P, Lesch KP (1995). Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. Journal of Neural Transmission 102, 247-254.
35. Heils A, Wichems C, Mössner R, Petri S, Glatz K, Bengel D, Riederer P, Murphy DL, Lesch KP (1998). Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons. Journal of Neuochemistry 40,932-939.
36. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR (In Press). A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological Psychiatry.
37. Hoyer D, Martin G (1997). 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharinacology 36, 419-428.
38. Huh SO, Park DH, Cho JY, Joh TH, Son JH (1994). A 6.1 kb 5′ upstream region of the mouse tryptophan hydroxylase gene directs expression of E. coli lacZ to major serotonergic brain regions and pineal gland in transgenic mice. Brain Research and Molecular Brain Research 24, 145-152.
39. Julius D (1991). Molecular biology of serotonin receptors. Annual Review of Neuroscience 14, 335-360.
40. Kaplitt MG, Makimura H (1997). Defective viral vectors as agents for gene transfer in the nervous system. Journal of Neuroscience Methods 7, 125-132.
41. Karpati G, Lochmüller H, Nalbantoglu J, Durham H (1996). The principle of gene therapy for the nervous system. Trends in Neuroscience 19, 49-54.
42. Lauder JM (1993). Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends in Neuroscience 16, 233-240.
43. Le Corre S, Sharp T, Young AH, Harrison PJ (1997). Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1) receptor mRNA expression in rat hippocampus after adrenalectomy. Psychopharmacology 130, 368-374.
44. Lesch KP (1997). Molecular biology, pharmacology, and genetics of the serotonin transporter: psychobiological and clinical implications. In: Baumgarten HG, Göthert M (Eds), Serotonergic Neurons and 5-HT Receptors in the CNS (pp. 671-705). New York: Springer, Berlin, Heidelberg.
45. Lesch KP (1999). Gene transfer to the brain: emerging therapeutic strategy in psychiatry? Biological Psychiatry 45, 247-253.
46. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P (1994). Organization of human serotonin transporter gene. Journal of Neural Transmission 95, 157-164.
47. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1483-1487.
48. Lesch KP, Jatzke S, Meyer J, Stöber G, Okladnova O, Mössner R, Riederer P (1999). Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression. Journal of Neural Transmission 106, 1223-1230.
49. Lesch KP, Mössner R (1998). Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders. Biological Psychiatry 44, 179-192.
50. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998). Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American Journal of Psychiatry 155, 207-213.
51. Lucas JJ, Segu L, Hen R (1997). 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptaminelB knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Molecular Pharmacology 51, 755-763.
52. Mendelson SD, McEwen BS (1992). Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55, 444-450.
53. Morinobu S, Strausbaugh H, Terwilliger R, Duman RS (1997). Regulation of c-Fos and NGF1-A by antidepressant treatments. Synapse 25, 313-320.
54. Olsen MA, Nawoschik SP, Schurman BR, Schmitt HL, Burno M, Smith DL, Schechter LE (1999). Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Research and Molecular Brain: Research 64, 255-263.
55. Parks CL, Shenk T (1996). The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. Journal of Biological Chemistry 271, 4417-4430.
56. Reichel RR, Jacob ST (1993). Control of gene expression by lipophilic hormones. FASEB Journal 7, 427-436.
57. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics 103, 273-279.
58. Samochowiec J, Lesch KP, Rottmann M, Smolka M, Syagailo YV, Okladnova O, Rommelspacher H, Winterer G, Schmidt LG, Sander T (1999). Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Research 86, 67-72.
59. Schuback DE, Mulligan EL, Sims KB, Tivol EA, Greenberg BD, Chang SF, Yang SL, Mau YC, Shen CY, Ho MS, Yang NH, Butler MG, Fink S, Schwartz CE, Berlin F, Breakefield XO, Murphy DL, Hsu YP (1999). Screen for MAOA mutations in target human groups. American Journal of Medical Genetics 88, 25-28.
60. Sen D, Gilbert W (1990). A sodium-potassium switch in the formation of four-stranded G4-DNA. Nature 344, 410-414.
61. Shih JC, Grimsby J, Chen K, Zhu QS (1993). Structure and promoter organization of the human monoamine oxidase A and B genes. Journal of Psychiatry and Neuroscience 18, 25-32.
62. Shih JC, Zhu Q, Chen K (1996). Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behavioral Brain Research 73, 59-62.
63. Simon MI, Strathmann MP, Gautam N (1991). Diversity of G proteins in signal transduction. Science 252, 802-808.
64. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molecular Psychiatry 3, 508-511.
65. Son JH, Chung JH, Huh SO, Park DH, Peng C, Rosenblum MG, Chung YI, Joh TH (1996). Immortalization of neuroendocrine pinealocytes from transgenic mice by targeted tumorigenesis using the tryptophan hydroxylase promoter. Brain Research and Molecular Brain Research 37, 32-40.
66. Sora I, Wichems C, Takahashi N, Li XF, Donovan D, Rovay R, Zeng Z, Lesch KP, Murphy DL, Uhl GR (1998). Cocaine reward models: conditioned place preference can be established in dopamine-and in serotonin-transporter knockout mice. Proceedings of the National Academy of Science USA 95, 7699-7704.
67. Storring JM, Charest A, Cheng P, Albert PR (1999). TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. Journal of Neurochemistry 72, 2238-2247.
68. Taylor CW (1990). The role of G proteins in transmembrane signalling. Biochemical Journal 272, 1-13.
69. Toth M (1996). Transcriptional regulation of the 5-HT2A receptor. Behavioral Brain Research 73, 183-186.
70. Toth M, Shenk T (1994). Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. Molecular Pharmacology 45, 1095-1100.
71. Tuszynski MH, Gage FH (1996). Somatic gene therapy for nervous system disease. Ciba Foundation Symposium 196, 85-97.
72. Verhaagen J, Hermens WTJMC, Dijkhuizen PA, Holtmaat AJGD, Gispen WH (1996). Use of viral vectors to promote neuroregeneration. Neuroscience 3, 275-283.
73. Xie E, Zhu L, Zhao L, Chang LS (1996). The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant. Genomics 35, 551-561.
74. Yau JL, Noble J, Widdowson J, Seckl JR (1997). Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Brain Research and Molecular Brain Research 45, 182-186.
75. Zhong P, Ciaranello RD (1995). Transnational regulation of hippocampal 5-HT1a receptors by corticosteroid hormones. Brain Research and Molecular Brain Research 29, 23-34.
76. Zhu Q, Shih JC (1997). An extensive repeat structure down-regulates human monoamine oxidase A promoter activity independent of an initiator-like sequence. Journal of Neurochemistry 69, 1368-1373.
77. Zhu QS, Chen K, Shih JC (1994). Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. Journal of Neuroscience 14, 7393-7403.
78. Zhu QS, Grimsby J, Chen K, Shih JC (1992). Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. Journal of Neuroscience 12, 4437-4446.